Evidence map›Paper›PMID 37096022›Full record

ArticleIn vitro models2022

3D spheroid culture to examine adaptive therapy response in invading tumor cells.

Felix Weiss, Nader Atlasy, Vince van Reijmersdal, Henk Stunnenberg, Cornelia Hulsbergen-Veelken, Peter Friedl

Open access · hybridAbstract read
In one paragraph

Article in In vitro models, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Felix WeissDepartment of Cell Biology, Radboud University Medical Centre, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-4224-9344
Nader AtlasyDepartment of Molecular Biology, Faculty of Science, Radboud University, 6525 AJ Nijmegen, The Netherlands.
Vince van ReijmersdalDepartment of Cell Biology, Radboud University Medical Centre, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Henk StunnenbergDepartment of Molecular Biology, Faculty of Science, Radboud University, 6525 AJ Nijmegen, The Netherlands.
Cornelia Hulsbergen-VeelkenDepartment of Cell Biology, Radboud University Medical Centre, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.
Peter FriedlDepartment of Cell Biology, Radboud University Medical Centre, P.O. Box 9101, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-0119-4041
Radboud University Nijmegen · NLThe University of Texas MD Anderson Cancer Center · US

Funding

European Research Council 617430
6 · The paper itself

Abstract

3D in vitro culture models of cancer cells in extracellular matrix (ECM) have been developed to investigate drug targeting and resistance or, alternatively, mechanisms of invasion; however, models allowing analysis of shared pathways mediating invasion and therapy resistance are lacking. To evaluate therapy response associated with cancer cell invasion, we here used 3D invasion culture of tumor spheroids in 3D fibrillar collagen and applied Ethanol-Ethyl cinnamate (EtOH-ECi) based optical clearing to detect both spheroid core and invasion zone by subcellular-resolved 3D microscopy. When subjected to a single dose of irradiation (4 Gy), we detected significant cell survival in the invasion zone. By physical separation of the core and invasion zone, we identified differentially regulated genes preferentially engaged in invading cells controlling cell division, repair, and survival. This imaging-based 3D invasion culture may be useful for the analysis of complex therapy-response patterns in cancer cells in drug discovery and invasion-associated resistance development. Supplementary Information: The online version contains supplementary material available at 10.1007/s44164-022-00040-x.

Indexed as

3D matrix cultureCancer invasionIrradiationMolecular profilingResistanceRNAseqSpheroidTherapy response

Identifiers

PMID37096022
PMCPMC10119213
OpenAlexW4324358615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.